Polyguluronate sulfate (PGS) attenuates immunological liver injury in vitro and in vivo
- 1 July 2018
- journal article
- research article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 114, 592-598
Abstract
No abstract availableKeywords
Funding Information
- NSFC-Shandong Joint Fund (U1606403, U1706210)
- Innovation Project of Qingdao National Laboratory for Marine Science and Technology (2015ASKJ02)
- National Natural Science Foundation of China (31500646, 81741146)
- Shandong Provincial Natural Science Foundation (ZR2017MH013)
- Shandong key scientific and technology program (2015ZDJS04002)
This publication has 21 references indexed in Scilit:
- Anti-HBV activity and mechanism of marine-derived polyguluronate sulfate (PGS) in vitroCarbohydrate Polymers, 2016
- Long-term monitoring drug resistance by ultra-deep pyrosequencing in a chronic hepatitis B virus (HBV)-infected patient exposed to several unsuccessful therapy schemesAntiviral Research, 2012
- Protective effect of andrographolide against concanavalin A-induced liver injuryNaunyn-Schmiedeberg's Archives of Pharmacology, 2011
- CD4 T cells in hepatic immune toleranceJournal of Autoimmunity, 2010
- Hydrogen from intestinal bacteria is protective for Concanavalin A-induced hepatitisBiochemical and Biophysical Research Communications, 2009
- Preparation of low-molecular-weight polyguluronate sulfate and its anticoagulant and anti-inflammatory activitiesCarbohydrate Polymers, 2007
- Current Treatment of Chronic Hepatitis B: Benefits and LimitationsSeminars in Liver Disease, 2005
- Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis BHepatology, 2004
- Immunology of hepatitis B infectionThe Lancet Infectious Diseases, 2002
- A T cell-dependent experimental liver injury in mice inducible by concanavalin A.Journal of Clinical Investigation, 1992